Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine

D. J. Weber, W. A. Rutala, G. P. Samsa, J. E. Santimaw and S. M. Lemon

Factors associated with lack of antibody response to the hepatitis B virus plasma vaccine were retrospectively evaluated by means of a logistic regression in 194 previously seronegative staff members of a community hospital. All subjects had received three doses of vaccine by intramuscular buttock injection using a 1-in, 23-gauge needle. Overall, only 55.7% of subjects developed detectable antibody to hepatitis B surface antigen in serum after immunization. The weight-height index served as a surrogate measure of obesity. Predictors of poor immunogenic response to hepatitis B vaccine included higher weight-height index, older age, and vaccine batch. Sex, race, timing of vaccine doses, and timing of postimmunization determination of antibody to hepatitis B surface antigen were not predictors of vaccine efficacy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunogenicity in humans of an edible vaccine for hepatitis B
Thanavala et al.
Proc. Natl. Acad. Sci. USA 2005;102:3378-3382.
ABSTRACT | FULL TEXT  

Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial
Halperin et al.
CMAJ 2003;169:111-117.
ABSTRACT | FULL TEXT  

A Randomized Trial of Alternative Two- and Three-Dose Hepatitis B Vaccination Regimens in Adolescents: Antibody Responses, Safety, and Immunologic Memory
Cassidy et al.
Pediatrics 2001;107:626-631.
ABSTRACT | FULL TEXT  

Hepatitis B Vaccination in Pregnancy: Factors Influencing Efficacy
INGARDIA et al.
Obstet Gynecol 1999;93:983-986.
ABSTRACT | FULL TEXT  

Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Pirofski and Casadevall
Clin. Microbiol. Rev. 1998;11:1-26.
ABSTRACT | FULL TEXT  

Vaccines to Prevent Viral Hepatitis
Lemon and Thomas
NEJM 1997;336:196-204.
FULL TEXT